Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $13,177 | 3 | 87.7% |
| Food and Beverage | $1,846 | 83 | 12.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $13,943 | 51 | $0 (2024) |
| CONMED Corporation | $175.00 | 1 | $0 (2024) |
| Romark Laboratories, LC | $167.06 | 2 | $0 (2020) |
| ABBVIE INC. | $147.66 | 10 | $0 (2024) |
| Boston Scientific Corporation | $110.38 | 1 | $0 (2024) |
| FUJIFILM Healthcare Americas Corporation | $92.20 | 1 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $86.62 | 6 | $0 (2022) |
| ERBE USA INC | $70.00 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $44.29 | 3 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $37.33 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $796.82 | 23 | Gilead Sciences, Inc. ($207.93) |
| 2023 | $358.19 | 15 | Gilead Sciences, Inc. ($312.82) |
| 2022 | $127.71 | 9 | Janssen Biotech, Inc. ($44.29) |
| 2021 | $58.00 | 4 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($44.42) |
| 2020 | $62.61 | 3 | Romark Laboratories, LC ($33.54) |
| 2019 | $161.15 | 3 | Romark Laboratories, LC ($133.52) |
| 2018 | $8,085 | 13 | Gilead Sciences, Inc. ($8,070) |
| 2017 | $5,374 | 16 | Gilead Sciences Inc ($5,326) |
All Payment Transactions
86 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.16 | General |
| 12/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.59 | General |
| 11/14/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: INFLAM | ||||||
| 11/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.54 | General |
| 11/08/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: VIROLOGY | ||||||
| 10/28/2024 | Boston Scientific Corporation | Acquire (Device) | Food and Beverage | In-kind items and services | $110.38 | General |
| Category: Acquire_ENDO | ||||||
| 10/24/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: LIVER DISEASE | ||||||
| 09/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.69 | General |
| 09/16/2024 | CONMED Corporation | CONMED BILIARY (Device), CONMED HEMOSTASIS | Food and Beverage | In-kind items and services | $175.00 | General |
| Category: GENERAL SURGERY | ||||||
| 09/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/28/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.36 | General |
| 06/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.65 | General |
| 05/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.69 | General |
| 04/13/2024 | FUJIFILM Healthcare Americas Corporation | FUJIFILM (Device) | Food and Beverage | In-kind items and services | $92.20 | General |
| Category: Medical Device | ||||||
| 04/13/2024 | ERBE USA INC | Vio3 APC3 (Device) | Food and Beverage | Cash or cash equivalent | $70.00 | General |
| Category: Gastroenterology | ||||||
| 03/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.57 | General |
| 03/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: IMMUNOLOGY | ||||||
| 03/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.69 | General |
| 02/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: IMMUNOLOGY | ||||||
| 02/05/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 01/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.00 | General |
| 01/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Immunology | ||||||
| 11/03/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.91 | General |
| 10/27/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.23 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 578 | 648 | $490,258 | $68,995 |
| 2022 | 12 | 641 | 714 | $519,677 | $77,415 |
| 2021 | 11 | 638 | 711 | $536,440 | $82,656 |
| 2020 | 12 | 515 | 587 | $336,236 | $59,074 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 160 | 214 | $65,912 | $14,659 | 22.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 52 | 53 | $87,185 | $11,588 | 13.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 36 | 36 | $59,220 | $7,980 | 13.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 77 | $30,800 | $7,570 | 24.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $22,747 | $5,299 | 23.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 32 | 32 | $46,848 | $4,702 | 10.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 35 | 35 | $51,240 | $3,756 | 7.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 31 | 31 | $13,950 | $3,440 | 24.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 42 | 42 | $45,486 | $3,210 | 7.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 39 | 40 | $43,320 | $2,962 | 6.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $11,200 | $2,843 | 25.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $12,350 | $985.30 | 8.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 143 | 192 | $59,136 | $13,709 | 23.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 103 | 126 | $52,740 | $12,770 | 24.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 44 | 44 | $72,380 | $9,320 | 12.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 63 | 63 | $31,867 | $7,625 | 23.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 33 | 33 | $54,285 | $7,281 | 13.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 48 | 48 | $70,272 | $6,547 | 9.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 33 | 33 | $48,312 | $4,677 | 9.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 30 | 30 | $13,500 | $3,308 | 24.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 42 | 42 | $45,486 | $2,989 | 6.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 12 | 12 | $12,804 | $2,304 | 18.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 28 | 28 | $30,324 | $2,147 | 7.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $6,108 | $1,669 | 27.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 16 | 16 | $15,200 | $1,119 | 7.4% |
About Dr. Christopher Deitch, MD
Dr. Christopher Deitch, MD is a Gastroenterology healthcare provider based in Mount Laurel, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528154903.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Deitch, MD has received a total of $15,024 in payments from pharmaceutical and medical device companies, with $796.82 received in 2024. These payments were reported across 86 transactions from 18 companies. The most common payment nature is "Consulting Fee" ($13,177).
As a Medicare-enrolled provider, Deitch has provided services to 2,372 Medicare beneficiaries, totaling 2,660 services with total Medicare billing of $288,141. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology, Gastroenterology
- Location Mount Laurel, NJ
- Active Since 10/05/2006
- Last Updated 04/02/2019
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1528154903
Products in Payments
- Epclusa (Drug) $373.03
- CONMED BILIARY (Device) $175.00
- Alinia (Drug) $133.52
- Livdelzi (Drug) $124.99
- Acquire (Device) $110.38
- FUJIFILM (Device) $92.20
- XIFAXAN (Drug) $73.57
- Vio3 APC3 (Device) $70.00
- DUPIXENT (Biological) $57.89
- MAVYRET (Drug) $57.73
- STELARA (Biological) $44.29
- ALINIA (Drug) $33.54
- RINVOQ (Biological) $31.14
- EVIS EXERA (Device) $29.94
- RESMETIROM (Drug) $19.89
- Vascepa (Drug) $17.70
- XELJANZ (Drug) $16.84
- CREON (Drug) $16.56
- OCALIVA (Drug) $15.76
- Cimzia (Drug) $14.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Mount Laurel
Adam Elfant, Md, MD
Gastroenterology — Payments: $445,803
Anthony Infantolino, M.d, M.D
Gastroenterology — Payments: $31,686
Dr. Jeffrey Kutscher, Md, MD
Gastroenterology — Payments: $12,782
Scott Cohen, Do, DO
Gastroenterology — Payments: $6,204
Adib Chaaya, Md, MD
Gastroenterology — Payments: $5,383
Yize Wang, M.d, M.D
Gastroenterology — Payments: $4,866